Earns Amgen
FILE - This April 20, 2010, file photo shows an exterior view of Amgen offices in Fremont, Calif. Drugmaker Amgen Inc. on Wednesday, Jan. 23, 2013 posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results fell a bit short of Wall Street expectations. (AP Photo/Paul Sakuma, File)
